Skip to main content
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. — Investor Relations & Filings

Ticker · STOK ISIN · US86150R1077 LEI · 549300RD25SS2DIJHJ67 US Manufacturing
Open in API
Filings indexed 559 across all filing types
Latest filing 2020-06-04 Declaration of Voting R…
Country US United States of America
Listing US STOK

About Stoke Therapeutics, Inc.

https://www.stoketherapeutics.com/

Stoke Therapeutics, Inc. is a biotechnology company focused on developing treatments for severe genetic diseases by addressing their underlying cause. The company utilizes its proprietary research platform, TANGO (Targeted Augmentation of Nuclear Gene Output), an RNA-based approach designed to restore protein levels. This technology works by upregulating protein expression from the healthy copy of a gene to compensate for a mutated or non-functioning copy, a mechanism particularly suited for haploinsufficient diseases. Stoke's lead investigational medicine, zorevunersen (STK-001), is in late-stage clinical development for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company is also advancing its platform to treat other genetic conditions, including autosomal dominant optic atrophy (ADOA).

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 3, 2020, reporting the results of the 2020 Annual Meeting of Stockholders. It includes voting results for director elections and ratification of the independent auditor. The document also includes a press release about the election of a new independent director. The content focuses on the submission of matters to a vote of security holders and the announcement of voting results. It is not a full annual report, earnings release, or management discussion. The key section is Item 5.07 Submission of Matters to a Vote of Security Holders, which corresponds to Declaration of Voting Results & Voting Rights Announcements. The document length is under 5,000 characters and contains detailed voting results, not just an announcement of a report. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2020-06-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-03 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-03 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-03 English
FORM 4 SUBMISSION
Director's Dealing
2020-05-26 English
FORM 4/A SUBMISSION
Director's Dealing
2020-05-26 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.